Abstract Submission Rules & Regulations
Abstract Submission Deadline: Thursday, 12 January 2023
- All accepted abstracts will be included in the Annual Meeting mobile app and will be published in the Journal of the Peripheral Nervous System (JPNS) as submitted.
The word limit for all abstracts is 300 words, NOT including title and authors.
Presenting authors of accepted abstracts will be required to register for the meeting (Junior Members presenting abstracts are eligible for gratis registration). Registration opens in early 2023.
- All presenting authors are expected to stand by their poster(s) for the full duration of their designated stand-by time. There will be no option to present an e-poster at the 2023 Annual Meeting.
- Tables, graphs, and images are not permitted.
- Avoid trade names whenever possible. Sometimes you need to say the trade name at least once for clarity – for instance – natalizumab (Tysabri).
Preparation of Your Abstract
- No identifying features such as names of hospitals, medical schools, clinics, or cities may be listed in the title or text of the abstract. Do not include the names of any of the authors. The names of authors and their affiliations (institutions) will be submitted online during the process.
- Abstracts previously presented at a national/international meeting may be submitted to the PNS. Please cite the meeting, location, and date of previous presentation. Abstracts cannot be previously published.
- The title cannot be longer than (15) words but should clearly indicate the nature of the study. Capitalize the first letter of each word within the title. Avoid abbreviations whenever possible.
- Abstracts should state briefly and clearly the purpose, methods, results, and conclusions of the work. There is a strict 300-word limit (title and authors not included).
- Clearly state the purpose of the abstract.
- Describe your selection of observations or experimental subjects.
- Present your results in a logical sequence.
- Emphasize new and important aspects of the study and conclusions that are drawn from them.
PNS Abstract Withdrawal Policy
It is the PNS’ expectation that all accepted abstracts will, under all usual circumstances, be presented in-person at the meeting in Copenhagen. If the presenting author cannot present an abstract in-person, a co-author is eligible to present on their behalf. Failure to present an accepted abstract may cause the author(s) to be ineligible for abstract submission at next year’s Annual Meeting. To request withdrawal of an abstract, please submit the request in writing to meetings@PNSociety.com.
Selection of Abstracts
The abstract review process is completed by the PNS Scientific Program Committee. As peers, they carefully review each abstract for content/consideration. The Editor-in-Chief of the JPNS is part of this peer review process and reviews the submission for publication.
Accepted abstracts will be published as a compilation in an abstract supplement of our Journal, the Journal of the Peripheral Nervous System (JPNS), under copyright by the Peripheral Nerve Society. Individual abstracts are not copyrighted by the Society, and you are free to publish or present your work elsewhere.
Abstract Prize Criteria
For ALL abstract prizes:
- The abstract presenter must be a current Junior Member of PNS at the time the abstract is submitted. Please click here for more information on PNS membership.
- The recipient is required to attend the Annual Meeting.
Arthur K. Asbury Prize: The abstract must pertain to GBS/CIDP/Inflammatory.
Richard and Mary Bunge Prize: The abstract must pertain to nerve biology.
Peter J. Dyck Prize: The abstract must pertain to diabetes.
J.W. Griffin Prize: The abstract must pertain to regeneration.
Anita Harding Prize: The presenting author must be female.
Pembroke Prize: The presenting author must be from Australia, New Zealand, or South Asia.
P.K. Thomas Prize: The abstract must pertain to inherited neuropathies.
Richard A.C. Hughes Prize: The abstract must pertain to clinical topics.
In evaluating each presentation, the prize committee will consider the quality of the presentation, groundbreaking/innovative results, and the quality of the presenter.